My Cart

MICA

MICA Overview

English NameMHC class I polypeptide-related sequence AApproved Drugs0
Drugs in Clinical Trials4Target Synonym
Highest Development StagePhase 1 Clinical
English NameMHC class I polypeptide-related sequence A
Target Synonym
Approved Drugs0
Drugs in Clinical Trials4
Highest Development StagePhase 1 Clinical

MICA Background

MHC class I polypeptide-related sequence A (MICA) belongs to the MHC class I family and MIC subfamily. MICA contains one Ig-like C1-type (immunoglobulin-like) domain. Unlike classical MHC class I molecules, MICA does not form a heterodimer with beta-2-microglobulin. MICA acts as a stress-induced self-antigen that is recognized by gamma delta T-cells. MICA is ligand for the KLRK1/NKG2D receptor. MICA bind to KLRK1 leads to cell lysis.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
IsuventatugCLN-619Phase 1 ClinicalCullinan MICA CorpCarcinoma, Non-Small-Cell Lung; Multiple Myeloma; Solid tumours
Details
FT-536FT-536Phase 1 ClinicalFate Therapeutics IncAbdominal Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Ovarian Neoplasms; Solid tumours
Details
FT-836FT-836; FT836Phase 1 ClinicalFate Therapeutics IncBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck
Details
DM-919DM-919; DM919Phase 1 ClinicalD2M Biotherapeutics IncNeoplasms; Solid tumours
Details
  • Product List
  • Clinical Drug Information